Ginkgo Bioworks Holdings WTS (DNABW) Net Income by Year
Ginkgo Bioworks Holdings WTS reported a net loss of $313K in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $21.6M in net income. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Ginkgo Bioworks Holdings WTS has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DNABW Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
DNABW Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Ginkgo Bioworks Holdings WTS financials
Frequently Asked Questions
Ginkgo Bioworks Holdings WTS reported a net loss of $313K in fiscal year 2025.
Ginkgo Bioworks Holdings WTS (DNABW) reported a $547K net loss in fiscal year 2024 and a $313K net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Ginkgo Bioworks Holdings WTS (DNABW) reported $21.6M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
Across the 7 fiscal years this page covers, Ginkgo Bioworks Holdings WTS (DNABW) net income went from -$119.3M in fiscal year 2019 to -$313K in fiscal year 2025.
Ginkgo Bioworks Holdings WTS (DNABW) reported -$46.7M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Ginkgo Bioworks Holdings WTS (DNABW) reported on that line in every period on record.